As part of the ongoing EMA-EC collaboration to improve understanding of biosimilar medicines in the EU, the European Medicines Agency (EMA) has published the following materials on biosimilars:

• A video on biosimilars for the general public in the following EU languages: Dutch, French, German, Italian, Polish, Portuguese and Spanish
  (EMA plans to publish further language versions at a later stage)
• The translations of the information guide on biosimilars for healthcare professionals into Dutch, French, German, Italian, Polish, Portuguese and Spanish
  (Translations into the remaining EU languages are expected by October 2018, subject to EMA’s business continuity planning due to relocation)

These educational materials on biosimilars, as well as the link to the Q&A for patients, are now available on EMA’s webpage on biosimilar medicines.You are encouraged to use and disseminate these materials and promote their use, as it will help to ensure that consistent public health messages on biosimilars reach EU citizens.

The information was presented at the EC’s fourth multi-stakeholder conference on biosimilar medicines in Brussels last month.

The EMA would like to thank all patients for their valuable contribution in helping to produce and review these educational materials.